Silk Road Medical, Inc. (NASDAQ:SILK) Q2 2022 Earnings Conference Call July 26, 2022 4:30 PM ET

Company Participants

Marissa Bych - Investor Relations

Erica Rogers - President and Chief Executive Officer

Lucas Buchanan - Chief Financial Officer and Chief Operating Officer

Conference Call Participants

Lily Baik - J.P. Morgan

Rick Wise - Stifel

Mike Polark - Wolfe Research

Anthony Pettinari - Citi

Adam Maeder - Piper Sandler

Operator

Ladies and gentlemen, thank you for standingby, and welcome to Silk Road Medical’s 2022 Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions]

I would now like to hand the conference over to Marissa Bych with Investor Relations.

Marissa Bych

Hi, thank you, and thank you all for joining today's call. Joining me are Erica Rogers, Chief Executive Officer; and Lucas Buchanan, Chief Financial Officer and Chief Operating Officer. Earlier today, Silk Road Medical released financial results for the three months ended June 30, 2022. A copy of the press release is available on the company's website.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.

All forward-looking statements, including, without limitation, those relating to our operating trends and future financial performance, expense management, expectations for hiring, and growth in our organization, physician training and adoption, market opportunity and penetration, commercial and international expansion, regulatory approvals, reimbursement, competition and product development are based upon our current estimates and various assumptions.

These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our quarterly report on Form 10-Q filed with the Securities and Exchange Commission on May 10, 2022.

This conference call contains time-sensitive information and is accurate only as of the live broadcast today, July 26, 2022. Silk Road Medical disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.